Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Up0.55% Nasdaq Up0.29%

Immunomedics Inc. (IMMU)

-NasdaqGM
3.83 Up 0.03(0.79%) Apr 15, 4:00PM EDT
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2013Jun 30, 2012Jun 30, 2011
Total Revenue 4,962   32,734   14,709  
Cost of Revenue393  427  419  
Gross Profit 4,569   32,307   14,290  
Operating Expenses
Research Development28,381  24,256  24,537  
Selling General and Administrative6,981  6,609  7,944  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (30,792) 1,443   (18,191)
Income from Continuing Operations
Total Other Income/Expenses Net19,350  32  3,888  
Earnings Before Interest And Taxes(11,442)1,475  (14,302)
Interest Expense -   -   -  
Income Before Tax(11,442)1,475  (14,302)
Income Tax Expense44  210  110  
Minority Interest105  114  174  
Net Income From Continuing Ops(11,382)1,378  (14,238)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (11,382) 1,378   (14,238)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (11,382) 1,378   (14,238)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.